Azenta (AZTA) Other Non-Current Assets (2010 - 2026)
Azenta's (AZTA) quarterly Other Non-Current Assets came in at $145.5 million in Q1 2026, up 60.48% year-on-year from $90.7 million in Q1 2025, and up 92.01% on a QoQ basis from $75.8 million in Q4 2025.
Azenta (AZTA) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Azenta (AZTA) has 17 years of Other Non-Current Assets data on file, last reported at $145.5 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 60.48% year-over-year to $145.5 million in Q1 2026; TTM through Mar 2026 was $145.5 million, a 60.48% increase from a year earlier, with the FY2025 full-year figure at $75.8 million, changed N/A from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $145.5 million, up from $75.8 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for AZTA reached as high as $542.2 million in Q3 2023 and fell as low as $23000.0 in Q1 2023.
- Historically, Other Non-Current Assets has averaged $99.3 million across 5 years, with a median of $75.8 million in 2025.
- Across the five-year window, Other Non-Current Assets plunged 99.86% in 2023 and surged 44052.17% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $75.0 million in 2022, then advanced by 2.95% to $77.2 million in 2023, then increased by 7.84% to $83.2 million in 2024, then slipped by 8.93% to $75.8 million in 2025, then jumped by 92.01% to $145.5 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $145.5 million in Q1 2026, $75.8 million in Q4 2025, and $73.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 376.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.08 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 210.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 848.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 39.83 Mn |
| 10 | Azenta | 1.30 Bn | 1.07 Bn | 125.74 Mn | 145.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 145.55 Mn |
| Dec 31, 2025 | 75.80 Mn |
| Sep 30, 2025 | 73.54 Mn |
| Jun 30, 2025 | 162.50 Mn |
| Mar 31, 2025 | 90.70 Mn |
| Dec 31, 2024 | 83.24 Mn |
| Sep 30, 2024 | 23.63 Mn |
| Jun 30, 2024 | 77.03 Mn |
| Mar 31, 2024 | 10.16 Mn |
| Dec 31, 2023 | 77.19 Mn |
| Sep 30, 2023 | 542.15 Mn |
| Jun 30, 2023 | 623,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | 74.98 Mn |
| Sep 30, 2022 | 181.48 Mn |
| Jun 30, 2022 | 53.30 Mn |
| Mar 31, 2022 | 16.76 Mn |
| Dec 31, 2021 | 15.02 Mn |
| Sep 30, 2021 | 311.39 Mn |
| Jun 30, 2021 | 85.17 Mn |